Bivalirudin: role in current percutaneous coronary intervention practice

被引：1
|
作者：
West, N [1 ]
机构：
[1] Gloucestershire Hosp NHS Fdn Trust, Gloucester GL1 3NN, England
[2] John Radcliffe Hosp, Oxford OX3 9DU, England
来源：
BRITISH JOURNAL OF HOSPITAL MEDICINE | 2005年 / 66卷 / 12期
关键词：
D O I：
10.12968/hmed.2005.66.12.20208
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Bivalirudin is the only thrombin-specific anticoagulant currently licensed in the UK for use as an anticoagulant during percutaneous coronary intervention. This review examines the rationale for, and data supporting, its use in contemporary percutaneous coronary intervention practice.
引用
收藏
页码：687 / 689
页数：3
相关论文
共 50 条
  • [11] Bivalirudin versus heparin with primary percutaneous coronary intervention
    Venetsanos, Dimitrios
    Lawesson, Ofia Sederholm
    James, Stefan
    Koul, Sasha
    Erlinge, David
    Swahn, Eva
    Alfredsson, Joakim
    AMERICAN HEART JOURNAL, 2018, 201 : 9 - 16
  • [12] The clinical and economic impact of bivalirudin for percutaneous coronary intervention
    Malik, Nikesh
    Gershlick, Anthony H.
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2013, 13 (06) : 699 - 706
  • [13] Should bivalirudin be the anticoagulant of choice for percutaneous coronary intervention?
    Cheuk-Kit Wong
    Harvey D White
    Nature Clinical Practice Cardiovascular Medicine, 2005, 2 : 384 - 385
  • [14] Postprocedure bivalirudin infusion for primary percutaneous coronary intervention
    Shah, Rahman
    Naz, Arshi
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2019, 94 (06) : 900 - 901
  • [15] Should bivalirudin be the anticoagulant of choice for percutaneous coronary intervention?
    Wong, CK
    NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE, 2005, 2 (08): : 384 - 385
  • [16] Percutaneous coronary intervention in patients with acute coronary syndrome: focus on bivalirudin
    Ramana, Ravi K.
    Lewis, Bruce E.
    VASCULAR HEALTH AND RISK MANAGEMENT, 2008, 4 (03) : 493 - 505
  • [17] Current Practice of Percutaneous Coronary Intervention in Patients With Coagulation Disorders
    El Khoury, Michel
    Karam, Boutros
    Tabet, Rabih
    Lafferty, James C.
    Snyder, Stavros Thomas
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (09)
  • [18] Heparin versus Bivalirudin in patients undergoing Percutaneous Coronary Intervention
    Rehmani, Ahmed
    Judkins, Chris
    Lee, Edmund
    Nguyen, Michael
    Whelan, Alan
    Schultz, Carl
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (11) : B135 - B135
  • [19] Use of Prolonged Bivalirudin Infusions Following Percutaneous Coronary Intervention
    Moser, Lynette R.
    Nemerovski, Carrie W.
    Good, Kelley L.
    CARDIOVASCULAR DRUGS AND THERAPY, 2011, 25 (03) : 267 - 276
  • [20] Safety and Efficacy of Bivalirudin for Percutaneous Coronary Intervention with Rotational Atherectomy
    Delhaye, Cedric
    Wakabayashi, Kohei
    Maluenda, Gabriel
    Ben-Dor, Itsik
    Torguson, Rebecca
    Xue, Zhenyi
    Suddath, William O.
    Satler, Lowell F.
    Pichard, Augusto D.
    Kent, Kenneth M.
    Lindsay, Joseph
    Waksman, Ron
    JOURNAL OF INTERVENTIONAL CARDIOLOGY, 2010, 23 (03) : 223 - 229
12345